Keeps On Working

Unlike other vaginal yeast infection creams that leak out and are messy, Gynazole·1®’s exclusive, proprietary bioadhesion technology stays at the site of the yeast infection longer and you only need one dose.
* Data on file. Therapeutic efficacy is based on clinical cure rate (relief of yeast infection symptoms) and microbiologic cure (pathogen eradication). The therapeutic efficacy rate after 30 days for the one dose treatment (Gynazole·1) was 62% as compared to 68% for the seven day treatment (miconazole-7). The clinical cure rate for miconazole-7 at 8-10 days was 96%. Based on these results, there is no statistically significant difference between these yeast infection treatments.
 
Footnote References
 
 
 
 
 
 
 
 
 
Fast Relief
FOR LESS
Give your patients
$15 off their next prescription of
Gynazole·1
Want more from
your doctor visit
  Our patient edu-
   ca tion brochure    contains informa-
   tion and a ques-
   tionare that can    help. more...
  Tell a Friend
Gynazole-1®   Have a friend
  who might be
  suffering from a
  yeast infection?
  Send e-mail
  Got Questions?
  We've Got an Answer!
   Frequently asked
   questions about yeast
   infections, treatments,
   and Gynazole·1. more...
Learn More about other Ther-Rx Products
Anti-infectives
 - Clindesse®
Advanced Prescription
Nutritionals
 - Encora®
Prescription Prenatals
- PreCare Premier™
- PrimaCare®
- PrimaCare® ONE
- PremesisRx®
Iron Deficiency
 - Repliva 21/7 ™
 
 
 
Home    |    Search    |    Contact Us    |    Site Directory    |    Gynazole·1 Safety Information
Resource Library    |    Prescribing Information    |    Ther-Rx & Women's Healthcare



© 2008 Therx-Rx Corporation Terms of Use of Site